Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for diarrhoea-predominant irritable bowel syndrome (IBS-D)
2010-018340-14Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Salcrozine in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by University of Nottingham. Primary endpoint: Effect on stool frequency. Started Oct 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2010-018340-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018340-14.